Endometrial histology and predictable clinical factors for endometrial disease in women with polycystic ovary syndrome
- PMID: 22384417
- PMCID: PMC3283042
- DOI: 10.5653/cerm.2011.38.1.42
Endometrial histology and predictable clinical factors for endometrial disease in women with polycystic ovary syndrome
Abstract
Objective: This study was aimed to investigate endometrial histology and to find predictable clinical factors for endometrial disease (hyperplasia or cancer) in women with polycystic ovary syndrome (PCOS).
Methods: We investigated the endometrial histology and analyzed the relationship between endometrial histology and clinical parameters, such as LH, FSH, estradiol, testosterone, fasting and 2 hours postprandial glucose and insulin, insulin resistance, body mass index, endometrial thickness, menstrual status from 117 women with PCOS. Statistical analysis was performed with chi square and t-test, p-value<0.05 was considered as statistically significant. And receiver operating characteristic curve was used to find predictable clinical factors for endometrial disease and to decide the cuff off values.
Results: In 117 women with PCOS, endometrial histologic profiles are as follows: proliferative phase in 90 women (76.9%), endometrial hyperplasia in 25 women (21.4%), and endometrial cancer in 2 women (1.7%). Of 25 women with endometrial hyperplasia, simple hyperplasia without atypia, complex hyperplasia without atypia and complex hyperplasia with atypia were diagnosed in 15 (12.8%), 6 (5.1%), 4 (3.4%) women, respectively. Age and endometrial thickness were significantly related with endometrial disease, p=0.013 and p=0.001, respectively. At the cut off level of 25.5 years in age, sensitivity and specificity predicting for endometrial disease were 70.4% and 55.6%, respectively (p=0.023). At the cut off level of 8.5 mm in endometrial thickness, sensitivity and specificity were 77.8% and 56.7%, respectively (p=0.000).
Conclusion: In women with PCOS, the incidence of endometrial hyperplasia and cancer were 21.4% and 1.7%. The age and endometrial thickness may be used as clinical determining factors for endometrial biopsy.
Keywords: Biopsy; Endometrial Hyperplasia; Endometrium; Human; Polycystic Ovary Syndrome.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures


Similar articles
-
Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome.Obstet Gynecol. 2001 Aug;98(2):325-31. doi: 10.1016/s0029-7844(01)01432-6. Obstet Gynecol. 2001. PMID: 11506853
-
Relationships between Serum Luteinizing Hormone Level, Endometrial Thickness and Body Mass Index in Polycystic Ovary Syndrome Patients with and without Endometrial Hyperplasia.Int J Fertil Steril. 2016 Apr-Jun;10(1):36-41. doi: 10.22074/ijfs.2016.4766. Epub 2016 Apr 5. Int J Fertil Steril. 2016. PMID: 27123198 Free PMC article.
-
Endometrial hyperplasia in asymptomatic subfertile population.J Gynecol Obstet Hum Reprod. 2022 Apr;51(4):102337. doi: 10.1016/j.jogoh.2022.102337. Epub 2022 Feb 10. J Gynecol Obstet Hum Reprod. 2022. PMID: 35151930
-
Endometrium in PCOS: Implantation and predisposition to endocrine CA.Best Pract Res Clin Endocrinol Metab. 2006 Jun;20(2):235-44. doi: 10.1016/j.beem.2006.03.005. Best Pract Res Clin Endocrinol Metab. 2006. PMID: 16772154 Review.
-
Uterine Function: From Normal to Polycystic Ovarian Syndrome Alterations.Curr Med Chem. 2018;25(15):1792-1804. doi: 10.2174/0929867325666171205144119. Curr Med Chem. 2018. PMID: 29210631 Review.
Cited by
-
Pathophysiology of heavy menstrual bleeding.Womens Health (Lond). 2016 Jan;12(1):3-13. doi: 10.2217/whe.15.81. Epub 2015 Dec 23. Womens Health (Lond). 2016. PMID: 26695831 Free PMC article. Review.
-
Weight-Loss and Metformin-Use Improve the Reversal Rate in Patients with Endometrial Hyperplasia.Int J Womens Health. 2024 Nov 1;16:1815-1828. doi: 10.2147/IJWH.S477045. eCollection 2024. Int J Womens Health. 2024. PMID: 39502651 Free PMC article.
-
Risk of endometrial cancer in patients with polycystic ovarian syndrome: A meta‑analysis.Oncol Lett. 2023 Mar 8;25(4):168. doi: 10.3892/ol.2023.13754. eCollection 2023 Apr. Oncol Lett. 2023. PMID: 36960190 Free PMC article.
-
High Fat Mass Index is Associated with Endometrial Hyperplasia in Polycystic Ovary Syndrome Patients: A Retrospective Study.Int J Womens Health. 2024 Nov 30;16:2065-2075. doi: 10.2147/IJWH.S491443. eCollection 2024. Int J Womens Health. 2024. PMID: 39640509 Free PMC article.
-
Comparing endometrial hysteroscopic and histological findings of infertile women with polycystic ovary syndrome and unexplained infertility: A cross-sectional study.Int J Reprod Biomed. 2020 Jan 27;18(1):33-40. doi: 10.18502/ijrm.v18i1.6195. eCollection 2019 Apr. Int J Reprod Biomed. 2020. PMID: 32043069 Free PMC article.
References
-
- Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352:1223–1236. - PubMed
-
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25. - PubMed
-
- Giudice LC. Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab. 2006;20:235–244. - PubMed
-
- Iatrakis G, Tsionis C, Adonakis G, Stoikidou M, Anthouli-Anagnostopoulou F, Parava M, et al. Polycystic ovarian syndrome, insulin resistance and thickness of the endometrium. Eur J Obstet Gynecol Reprod Biol. 2006;127:218–221. - PubMed
-
- Balen A. Polycystic ovary syndrome and cancer. Hum Reprod Update. 2001;7:522–525. - PubMed
LinkOut - more resources
Full Text Sources